{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:18:53Z","timestamp":1787570333315,"version":"build-2736575974"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many drugs prescribed for individuals with schizophrenia have anticholinergic effects. When these medications are used together, they can create a substantial overall Anticholinergic Burden (ACB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to assess the prevalence of ACB and its predictors among patients with schizophrenia at selected comprehensive specialized hospitals in Northwest Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A multicenter cross sectional study was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included 406 patients with schizophrenia at selected specialized hospitals in Northwest Ethiopia between June and August 2022. Study participants were recruited using systematic random sampling. The Anticholinergic Cognitive Burden Score (ACBS) was used to assess ACB. Data were entered using EpiData version 4.6.0 and analyzed with SPSS version 26. Multivariable logistic regression analysis was performed to determine the predictors of high ACB, with variables having a p-value &lt; 0.05 at a 95% confidence interval considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of high ACB was 34.2%. Older patients [Adjusted Odds Ratio (AOR) = 3.26, 95% CI: 1.17, 9.08 P: 0.024], comorbidity [AOR =2.29, 95% CI: 1.24, 4.24, P: 0.008], polypharmacy [AOR = 2.54, 95% CI: 1.35, 4.76, P: 0.004], and Antipsychotic Polypharmacy (APP) [AOR = 2.15, 95% CI: 1.21, 3.82, P: 0.009] were significantly associated with ACB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, one-third of patients were exposed to high ACB. Old aged patients, those with comorbidity, polypharmacy, and APP need routine follow-up and screening in order to reduce high anticholinergic exposure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20451253261481515","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:37:41Z","timestamp":1787323061000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticholinergic burden and its predictors among patients with schizophrenia in Northwest Ethiopia: An institutional-based cross sectional study"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3026-6584","authenticated-orcid":false,"given":"Fasil Bayafers","family":"Tamene","sequence":"first","affiliation":[{"name":"Debre Markos University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew Yitayew","family":"Tarekegn","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-8792","authenticated-orcid":false,"given":"Tilaye Arega","family":"Moges","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-4551","authenticated-orcid":false,"given":"Samuel Berihun","family":"Dagnew","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2616-397X","authenticated-orcid":false,"given":"Tigabu Eskeziya","family":"Zerihun","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Temeche","family":"Kassaw","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn Addis","family":"Mussie","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-4014","authenticated-orcid":false,"given":"Woretaw Sisay","family":"Zewdu","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Agegnew","family":"Wondm","sequence":"additional","affiliation":[{"name":"Debre Tabor University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09552"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.3.022806.091529"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.3360"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20081212"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-014-0230-0"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015596998"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.04.019"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.12291"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.229"},{"key":"e_1_3_8_11_2","first-page":"8","article-title":"Cognitive deficits in patients with schizophrenia: effects and treatment","volume":"68","author":"Keefe RS","year":"2007","unstructured":"Keefe RS. Cognitive deficits in patients with schizophrenia: effects and treatment. Journal of Clinical Psychiatry 2007; 68: 8\u201313.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1081968"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09665-4"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1994.tb01487.x"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/20420986241259624"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00185.x"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1165664"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0362-5"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.2217\/1745509X.4.3.311"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13692"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800504"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6191074"},{"key":"e_1_3_8_24_2","volume-title":"Medication safety in polypharmacy: technical report","author":"Organization WH","year":"2019","unstructured":"Organization WH. Medication safety in polypharmacy: technical report. World Health Organization, 2019."},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574886315666201026123655"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnu.2023.03.006"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12321"},{"key":"e_1_3_8_28_2","article-title":"Anticholinergic Burden as a Precipitating Factor for Delirium Spectrum Disorders in Schizophrenia Spectrum and Bipolar Disorders: A Case-Crossover Study Based on the French Nationwide Claims Database","author":"Vidal N","year":"2025","unstructured":"Vidal N, Frileux S, Passerieux C, et al. Anticholinergic Burden as a Precipitating Factor for Delirium Spectrum Disorders in Schizophrenia Spectrum and Bipolar Disorders: A Case-Crossover Study Based on the French Nationwide Claims Database. Journal of Psychiatric Research 2025.","journal-title":"Journal of Psychiatric Research"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jppr.1303"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205897"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5084"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.5455\/medscience.2023.05.062"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae151"},{"key":"e_1_3_8_34_2","article-title":"Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study","volume":"382","author":"Huang W-C","year":"2023","unstructured":"Huang W-C, Yang AS-H, Hsiang-Te Tsai D, et al. Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study. bmj 2023; 382.","journal-title":"bmj"},{"key":"e_1_3_8_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu185"},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290037"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05584-z"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253261481515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20451253261481515","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253261481515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:19:56Z","timestamp":1787566796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20451253261481515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"alternative-id":["10.1177\/20451253261481515"],"URL":"https:\/\/doi.org\/10.1177\/20451253261481515","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"20451253261481515"}}